137 related articles for article (PubMed ID: 27890361)
1. Iron dysregulation in beta-thalassemia.
Leecharoenkiat K; Lithanatudom P; Sornjai W; Smith DR
Asian Pac J Trop Med; 2016 Nov; 9(11):1035-1043. PubMed ID: 27890361
[TBL] [Abstract][Full Text] [Related]
2. Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.
Saad HKM; Abd Rahman AA; Ab Ghani AS; Taib WRW; Ismail I; Johan MF; Al-Wajeeh AS; Al-Jamal HAN
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052868
[TBL] [Abstract][Full Text] [Related]
3. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
Porter J; Taher A; Viprakasit V; Kattamis A; Coates TD; Garbowski M; Dürrenberger F; Manolova V; Richard F; Cappellini MD
Expert Rev Hematol; 2021 Jul; 14(7):633-644. PubMed ID: 34324404
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin-ferroportin axis in health and disease.
Ginzburg YZ
Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
[TBL] [Abstract][Full Text] [Related]
5. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease.
Ginzburg YZ
Vitam Horm; 2023; 123():249-284. PubMed ID: 37717987
[TBL] [Abstract][Full Text] [Related]
7. Iron metabolism and iron disorders revisited in the hepcidin era.
Camaschella C; Nai A; Silvestri L
Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin.
Ganz T
Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
[TBL] [Abstract][Full Text] [Related]
10. Iron age: novel targets for iron overload.
Casu C; Rivella S
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):216-21. PubMed ID: 25696858
[TBL] [Abstract][Full Text] [Related]
11. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.
Nemeth E
Adv Hematol; 2010; 2010():750643. PubMed ID: 20066043
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of ferroportin gene expression in β(0)-thalassemia/Hb E disease.
Sornjai W; Jaratsittisin J; Khungwanmaythawee K; Svasti S; Fucharoen S; Lithanatudom P; Smith DR
Ann Hematol; 2016 Feb; 95(3):387-96. PubMed ID: 26666535
[TBL] [Abstract][Full Text] [Related]
13. Liver iron sensing and body iron homeostasis.
Wang CY; Babitt JL
Blood; 2019 Jan; 133(1):18-29. PubMed ID: 30401708
[TBL] [Abstract][Full Text] [Related]
14. [Hepcidin--the discovery of a small protein with a pivotal role in iron homeostasis].
Sela BA
Harefuah; 2008 Mar; 147(3):261-6, 276. PubMed ID: 18488871
[TBL] [Abstract][Full Text] [Related]
15. [Progress in iron metabolism research].
Kawabata H
Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
[TBL] [Abstract][Full Text] [Related]
16. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
[TBL] [Abstract][Full Text] [Related]
17. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Targeting of the Hepcidin/Ferroportin Axis.
Sebastiani G; Wilkinson N; Pantopoulos K
Front Pharmacol; 2016; 7():160. PubMed ID: 27445804
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
20. What regulates hepcidin in poly-transfused β-Thalassemia Major: erythroid drive or store drive?
Chauhan R; Sharma S; Chandra J
Indian J Pathol Microbiol; 2014; 57(1):39-42. PubMed ID: 24739829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
